Results 31 to 40 of about 1,895 (212)
Résistance médicamenteuse d'isolats récents de Trypanosoma brucei et Trypanosoma congolense
Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1988 Des études ont été menées sur des souris pour déterminer la sensibilité aux médicaments d’isolats récents de Trypanosoma brucei et Trypanosoma congolense. Chacune des onze souches de T. congolense et des cinq souches de T. brucei, toutes isolées sur des
R.A. Joshua
doaj +1 more source
Essai de l’efficacité du Cymelarsan™ sur Trypanosoma evansi chez le dromadaire
Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1989 L’expérimentation au Niger d’une nouvelle molécule arsenicale, susceptible d’être utilisée dans le traitement de la trypanosomose cameline à Trypanosoma evansi a démontré, au cours d’un essai d’efficacité effectué sur 8 jeunes dromadaires infestés ...
Pierre Tager-Kagan +2 more
doaj +1 more source
Trypanocidal Activity of Flavanone Derivatives [PDF]
Molecules, 2020 Chagas disease, also known as American trypanosomiasis, is classified as a neglected disease by the World Health Organization. For clinical treatment, only two drugs have been on the market, Benznidazole and Nifurtimox, both of which are recommended for use in the acute phase but present low cure rates in the chronic phase.
Gabriela Maciel Diogo +5 more
openaire +3 more sources
Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux, 1995 La sensibilité de douze souches de Trypanozoon isolées de bovins semi-nomades provenant de foyers endémiques connus de maladie du sommeil situés dans le Centre et au Nord du Nigeria a été étudiée vis-à-vis de deux trypanocides, l'acéturate de diminazène (
A.I. Kalu
doaj +1 more source
Integrated cost-benefit analysis of tsetse control and herd productivity to inform control programs for animal African trypanosomiasis [PDF]
, 2018 Animal African trypanosomiasis (AAT) and its tsetse vector are responsible for annual losses estimated in billions of US dollars ($). Recent years have seen the implementation of a series of multinational interventions.
Chilongo, K +7 more
core +1 more source
Anti-Trypanosoma cruzi action of a new benzofuran derivative based on amiodarone structure [PDF]
, 2018 Chagas disease is a neglected tropical affection caused by the protozoan parasite Trypanosoma cruzi. There is no current effective treatment since the only two available drugs have a limited efficacy and produce side effects.
Benaim, Gustavo +4 more
core +1 more source
Integrated control of chagas disease for its elimination as public health problem: A review [PDF]
, 2015 Chagas disease or American trypanosomiasis is, together with geohelminths, the neglected disease that causes more loss of years of healthy life due to disability in Latin America.
Segura, Elsa Leonor +1 more
core +4 more sources
BMC Complementary Medicine and Therapies, 2021 Background Parasite persistence, exacerbated and sustained immune response, and continuous oxidative stress have been described to contribute to the development of the cardiac manifestations in Chronic Chagas Disease. Nevertheless, there are no efficient
Wendy Lorena Quintero +5 more
doaj +1 more source
Independence from kinetoplast DNA maintenance and expression is associated with multi-drug resistance in Trypanosoma brucei in vitro [PDF]
, 2014 It is well known that several antitrypanosomatid drugs accumulate in the parasite's mitochondrion, where they often bind to the organellar DNA, the kinetoplast.
A. Schnaufer +32 more
core +1 more source
Nature Communications, 2019 Trypanosoma brucei relies on uptake and conversion of purines from the host, which constitutes a potential drug target. Here, Hulpia et al. combine structural elements from known trypanocidal nucleoside analogues and develop a potent trypanocide with ...
Fabian Hulpia +9 more
doaj +1 more source